Name | APTEKA N 24, OOO |
---|
INN | 1660035386 |
---|
KPP | 166001001 |
---|
OGRN | 1021603624052 |
---|
OKPO | 34726004 |
---|
Address | 420029, Respublika Tatarstan (tatarstan), g. Kazan', ul. Sibirskiy trakt, d. D.7/6 |
---|
Phone | 272-95-88 |
|
OKVED code | Type | Name of activity type |
---|
47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores | All types of activities | 68.20 | Additional activity | Renting and operating of own or leased land, buildings and dwellings | 73.20 | Additional activity | Market research and public opinion polling | 77.11 | Additional activity | Renting and leasing of cars and light motor vehicles |
Registration date | 13.11.2002 |
---|
Registering department | INSPEKTSIYA MNS ROSSII PO SOVETSKOMU RAYONU G.KAZANI RESPUBLIKI TATARSTAN |
---|
|
APTEKA N 24, OOO (Tatarstan, Republic; INN 1660035386) was registered on 13 Nov 2002. The company's authorized capital as of July 1, 2012 was 255452 rub. Type of ownership of APTEKA N 24, OOO - Limited liability companies. Form of ownership of APTEKA N 24, OOO - Private property. Principal activities of APTEKA N 24, OOO: retailing drugs in specialized stores (pharmacies) (47.73), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74), retailing of cosmetics and personal hygiene products in specialized stores (47.75). |
Economic indicators2024
Net profit (RAS) of APTEKA N 24, OOO dropped in 2024 8.20 times to 540.00 thousand RUB from 4.43 million RUB over the same period in 2023, the company informed. Revenue increased in the accounting period by 14.69% to 111.15 million RUB from 96.92 million RUB over 2023; cost of goods sold grew by 17.26% to 83.28 million RUB from 71.02 million RUB; sales profit fell 2.53 times to 2.56 million RUB from 6.48 million RUB. 2023
Net profit (RAS) of APTEKA N 24, OOO dropped in 2023 by 33.85% to 4.43 million RUB from 6.69 million RUB over the same period in 2022, the company informed. Revenue decreased in the accounting period by 8.90% to 96.92 million RUB from 106.39 million RUB in 2022; cost of goods sold decreased by 11.10% to 71.02 million RUB from 79.89 million RUB; sales profit fell by 21.73% to 6.48 million RUB from 8.27 million RUB. 2022
Net profit (RAS) of APTEKA N 24, OOO dropped in 2022 by 33.58% to 6.69 million RUB from 10.08 million RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period by 3.20% to 106.39 million RUB from 109.91 million RUB in 2021; cost of goods sold decreased by 1.08% to 79.89 million RUB from 80.76 million RUB; sales profit fell by 16.90% to 8.27 million RUB from 9.96 million RUB. 2021
Net profit (RAS) of APTEKA N 24, OOO dropped in 2021 2.59 times to 10.08 million RUB from 26.12 million RUB over the same period in 2020, the company informed. Revenue decreased in the accounting period by 27.22% to 109.91 million RUB from 151.02 million RUB in 2020; cost of goods sold decreased by 25.85% to 80.76 million RUB from 108.92 million RUB; sales profit fell 2.43 times to 9.96 million RUB from 24.21 million RUB. 2020
Net profit (RAS) of APTEKA N 24, OOO grew over 2020 4.02 times to 26.12 million RUB from 6.50 million RUB over 2019, the company informed. Revenue increased in the accounting period 2.71 times to 151.02 million RUB from 55.74 million RUB over 2019; cost of goods sold grew 2.72 times to 108.92 million RUB from 40.09 million RUB; sales profit went up 3.88 times to 24.21 million RUB from 6.24 million RUB. 2018
Net profit (RAS) of APTEKA N 24, OOO dropped in 2018 by 35.67% to 3.67 million RUB from 5.71 million RUB over the same period in 2017, the company informed. Revenue decreased in the accounting period by 13.62% to 30.59 million RUB from 35.42 million RUB in 2017; cost of goods sold decreased by 15.97% to 21.89 million RUB from 26.05 million RUB; sales profit fell by 33.75% to 3.10 million RUB from 4.68 million RUB. 2017
Net profit (RAS) of APTEKA N 24, OOO dropped in 2017 by 26.52% to 5.71 million RUB from 7.77 million RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 12.84% to 35.42 million RUB from 40.63 million RUB in 2016; cost of goods sold decreased by 10.27% to 26.05 million RUB from 29.03 million RUB; sales profit fell by 29.00% to 4.68 million RUB from 6.60 million RUB. 2012
Net profit (RAS) of Apteka 24, OOO grew over 2012 by 43.81% to 9.24 million RUB from 6.42 million RUB over 2011, the company informed. Revenue increased in the accounting period by 26.12% to 80.07 million RUB from 63.48 million RUB over 2011; cost of goods sold grew by 22.39% to 70.62 million RUB from 57.70 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|